(Q54563143)

1 June 2018

meta-analysis

0 references

title

Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy. (English)

1 reference

1 June 2018

author

Charlotte Manisty

8

1 reference

1 June 2018

Zhongbo Chen

Zhongbo Chen

2

0 references

Cecilia Linde

Cecilia Linde

6

0 references

Kenneth Dickstein

5

Kenneth Dickstein

1 reference

1 June 2018

Zachary I. Whinnett

3

Zachary I Whinnett

1 reference

1 June 2018

author name string

S M Afzal Sohaib

1

1 reference

1 June 2018

Sonia Bouri

4

1 reference

1 June 2018

David L Hayes

7

1 reference

1 June 2018

Darrel P Francis

9

1 reference

1 June 2018

publication date

1 December 2013

1 reference

1 June 2018

European Journal of Heart Failure

published in

1 reference

1 June 2018

volume

15

1 reference

1 June 2018

issue

12

1 reference

1 June 2018

page(s)

1419-1428

1 reference

1 June 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Cardiac resynchronization in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Cardiac resynchronization therapy in patients undergoing open-chest cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

The limit of plausibility for predictors of response: application to biventricular pacing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Why most published research findings are false

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

What is treatment success in cardiac resynchronization therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Long-term reverse remodeling with cardiac resynchronization therapy: results of extended echocardiographic follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Long-Term Prognosis After Cardiac Resynchronization Therapy Is Related to the Extent of Left Ventricular Reverse Remodeling at Midterm Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Why are some studies of cardiovascular markers unreliable? The role of measurement variability and what an aspiring clinician scientist can do before it is too late

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Atrioventricular and interventricular delay optimization and response quantification in biventricular pacing: arrival of reliable clinical algorithms and research protocols, and how to distinguish them from unreliable counterparts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Maximizing patient benefit from cardiac resynchronization therapy with the addition of structured exercise training: a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Cardiac-resynchronization therapy for mild-to-moderate heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

The European CRT Survey: 1 year (9-15 months) follow-up results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT139

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFT139

1 reference

1 June 2018

1 reference

1 June 2018